Clinical Trials Directory

Trials / Completed

CompletedNCT03348241

Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study

Randomized Controlled Trial on the Effect of Gum Arabic to Reduce Incidence of Oral Mucositis Induced by Chemotherapy for Cancer Patients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
386 (actual)
Sponsor
University of Science and Technology, Yemen · Academic / Other
Sex
All
Age
14 Years – 83 Years
Healthy volunteers
Not accepted

Summary

This study was designed to investigate the effect of Gum Arabic (GA) on cancer patients to prevent chemotherapy-induced oral mucositis. Cancer patients who will receive chemotherapy were divided into two groups; study "Gum Arabic" group (which received GA with chemotherapy) and control group (chemotherapy alone); and the participants were recruited to reach 190 patients in the study group and 184 patients in control group. This clinical trial was conducted in outpatient chemotherapy sections at Radiation and Isotopes Center of Khartoum. This study was designed to test the theory that say the chemotherapy-induced oral mucositis will significantly decrease after ingestion 30 grams as daily dose of Gum Arabic in a form of solution for six weeks during therapy.

Conditions

Interventions

TypeNameDescription
DRUGGum ArabicGum acacia, also known as Gum Arabic is exuded from acacia trees; mainly from Acacia Senegal (gum Hashab or Kordofan gum) which was used in this study.
DRUGChemotherapyPatients of control group and study group (Gum Arabic group) received chemotherapy according to type and stage of cancer.
BEHAVIORALLifestyle counselingLifestyle counseling pertaining to the optimal nutrition and daily routine for oral hygiene.

Timeline

Start date
2015-10-26
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2017-11-20
Last updated
2017-11-20

Source: ClinicalTrials.gov record NCT03348241. Inclusion in this directory is not an endorsement.